Serum IL-16, not IL-15, was elevated in early second trimester of pregnancy in women who subsequently developed preeclampsia

Clinica Chimica Acta

Volumn 383, Issue 1-2, 2007, Pages 175-177

  Lu, Shiming ^a   Wang, Hanzhi ^a   Shi, Yaping ^b   Sun, Yali ^a   Huang, Hefeng ^a   Dong, Minyue ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Fuyang Women's and Children's Hospital of Zhejiang Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 16;

ADULT; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOPATHOGENESIS; LETTER; PREECLAMPSIA; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ADULT; FEMALE; HUMANS; INTERLEUKIN-15; INTERLEUKIN-16; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; UP-REGULATION;

EID: 34347339450     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.04.022     Document Type: Letter

References (26)

1. Roberts J.M., and Gammill H.S. Preeclampsia: recent insights. Hypertension 46 6 (2005) 1243-1249
2. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 5728 (2005) 1592-1594
3. Redman C.W., and Sargent I.L. Preeclampsia and the systemic inflammatory response. Semin Nephrol 24 6 (2004) 565-570
4. Saftlas A.F., Beydoun H., and Triche E. Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstet Gynecol 106 1 (2005) 162-172
5. Matthiesen L., Berg G., Ernerudh J., Ekerfelt C., Jonsson Y., and Sharma S. Immunology of preeclampsia. Chem Immunol Allergy 89 (2005) 49-61
6. Hu W., Wang H., Wang Z., Huang H., and Dong M. Elevated serum levels of interleukin-15 and interleukin-16 in preeclampsia. J Reprod Immunol 73 (2007) 166-171
7. Lodolce J., Burkett P., Koka R., et al. Interleukin-15 and the regulation of lymphoid homeostasis. Mol Immunol 39 9 (2002) 537-544
8. Becknell B., and Caligiuri M.A. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol 86 (2005) 209-239
9. Carson W.E., Giri J.G., Lindemann M.J., et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180 4 (1994) 1395-1403
10. Mathy N.L., Scheuer W., Lanzendorfer M., et al. Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology 100 1 (2000) 63-69
11. Wilson K.C., Center D.M., and Cruikshank W.W. The effect of interleukin-16 and its precursor on T lymphocyte activation and growth. Growth Factors 22 2 (2004) 97-104
12. Pinsonneault S., El Bassam S., Mazer B., Cruikshank W.W., and Laberge S. IL-16 inhibits IL-5 production by antigen-stimulated T cells in atopic subjects. J Allergy Clin Immunol 107 3 (2001) 477-482
13. Chaouat G., Zourbas S., Ostojic S., et al. A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 53 1-2 (2002) 241-256
14. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 99 1 (2002) 159-167
15. Eneroth E., Remberger M., Vahlne A., and Ringden O. Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia. Acta Obstet Gynecol Scand 77 6 (1998) 591-593
16. Hamai Y., Fujii T., Yamashita T., et al. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 38 2 (1997) 89-93
17. Serin I.S., Ozcelik B., Basbug M., Kilic H., Okur D., and Erez R. Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 100 2 (2002) 143-145
18. Williams M.A., Farrand A., Mittendorf R., et al. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 149 4 (1999) 323-329
19. Omu A.E., Al-Qattan F., Diejomaoh M.E., and Al-Yatama M. Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium. Acta Obstet Gynecol Scand 78 8 (1999) 675-680
20. Clausen T., Djurovic S., Reseland J.E., Berg K., Drevon C.A., and Henriksen T. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?. Placenta 23 5 (2002) 380-385
21. Gratacos E., Filella X., Palacio M., Cararach V., Alonso P.L., and Fortuny A. Interleukin-4, interleukin-10, and granulocyte-macrophage colony stimulating factor in second-trimester serum from women with preeclampsia. Obstet Gynecol 92 5 (1998) 849-853
22. Djurovic S., Clausen T., Wergeland R., Brosstad F., Berg K., and Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG 109 7 (2002) 759-764
23. El Bassam S., Pinsonneault S., Kornfeld H., Ren F., Menezes J., and Laberge S. Interleukin-16 inhibits interleukin-13 production by allergen-stimulated blood mononuclear cells. Immunology 117 1 (2006) 89-96
24. Huang X., Huang H., Dong M., Yao Q., and Wang H. Serum and placental interleukin-18 are elevated in preeclampsia. J Reprod Immunol 65 1 (2005) 77-87
25. Dong M., Wang Z., and He J. Serum T helper 1-and 2-type cytokines in preeclampsia. Int J Gynaecol Obstet 89 3 (2005) 288-290
26. Dong M., He J., Wang Z., Xie X., and Wang H. Placental imbalance of Th1- and Th2-type cytokines in preeclampsia. Acta Obstet Gynecol Scand 84 8 (2005) 788-793